首页 > 市场调查报告书 > 製药

再生医学细胞疗法

欧洲生物生产市场预测至 2030 年 - 区域分析 - 按产品、应用、设备和最终用户

市场调查报告书

商品编码

1510612

欧洲生物生产市场预测至 2030 年 - 区域分析 - 按产品、应用、设备和最终用户

Europe Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 113 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲生物生产市场价值为55.1506亿美元，预计到2030年将达到147.898亿美元；预计2022年至2030年复合年增长率为13.1%。

慢性病盛行率不断上升推动欧洲生物生产市场

心血管疾病（CVD）、神经系统疾病、自体免疫疾病和癌症是全球造成死亡和残疾率很高的慢性疾病。根据世界卫生组织 (WHO) 的数据，CVD 是全球第一大死因，估计每年夺去 1,790 万人的生命。癌症也是全世界死亡的主要原因之一，影响着大量人口。因此，它给社会带来了巨大的经济负担。据世界卫生组织称，2020 年，全球约有 1,000 万人死于癌症。然而，越来越多的关于开发有效治疗疾病的研究正在积极影响市场的成长。基因疗法和细胞疗法正在改变癌症治疗格局；例如，诺华公司的Kymriah用于治疗瀰漫性大B细胞淋巴瘤。

此外，患者、专家、初级保健临床医生和其他医疗保健专业人员认识到生物相似药是有效且安全的药物，正在推动对生物相似药的需求。此外，生物相似药有助于改善数百万患者的生活，同时每年为医疗保健系统节省数十亿美元。它们是治疗许多疾病的有效且具成本效益的选择，包括慢性皮肤病和肠道疾病，如克罗恩病、牛皮癣、肠躁症和结肠炎；糖尿病;自体免疫疾病；癌症;肾臟状况；和关节炎。

随着慢性病盛行率的快速增长，用于治疗危及生命的疾病的生物生产的需求在过去五年中迅速增长，从而推动了生物生产市场的发展。

欧洲生物生产市场概况

欧洲生物生产市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲在全球生物生产市场中占据重要地位，预计 2022-2030 年复合年增长率显着。慢性病盛行率的不断上升导致产品上市和批准数量不断增加，技术进步和投资也不断增加，从而促进了该地区的市场成长。

生物相似药引入了竞争并提高了生物製剂的可负担性，最终提供节省成本和增值服务来支持患者护理和医疗保健行业。医疗保健专业人员可以以更低的成本使用高品质的生物製剂治疗更多患者。由于节省成本的巨大潜力，德国卫生部推出了一项新法律来增加生物相似药的采用。由于一些欧盟 (EU) 国家允许药剂师取代生物相似药，这将代表实践中的重大变化，特别是对德国而言。此外，医疗保健提供者如德国法兰克福的 PHI 骨科物理治疗中心、德国国际诊所； CBC Health 慕尼黑，德国；和其他提供者为各种慢性疾病提供干细胞疗法，如糖尿病视网膜病变、视神经神经炎和类风湿性关节炎。预计这将在未来几年增加细胞疗法的采用。此外，国际参与者之间越来越多的合作伙伴关係也促进了市场的成长。例如，2020 年 11 月，Hitachi Chemical Advanced Therapeutics Solutions, LLC 和 apceth Biopharma GmbH 扩大了与 Bluebird Bio 的关係，为多种疗法的临床和商业供应提供长期开发和製造服务协议，包括扩大在欧洲ZYNTEGLO 是一种治疗输血依赖性B 地中海型贫血(TDT) 的一次性基因疗法。因此，随着德国政府越来越多地采用生物相似药，该市场预计将蓬勃发展。

欧洲生物生产市场收入及 2030 年预测（百万美元）

欧洲生物生产市场细分

欧洲生物生产市场分为产品、应用、设备、最终用户和国家。

根据产品，欧洲生物生产市场分为生物製剂和生物相似药、疫苗、细胞和基因疗法、核酸疗法等。到 2022 年，生物製剂和生物相似药领域将占据欧洲最大的生物生产市场。

在应用方面，欧洲生物生产市场分为类风湿性关节炎、血液疾病、癌症、糖尿病、心血管疾病等。到 2022 年，癌症领域将占据欧洲最大的生物生产市场。

依设备划分，欧洲生物生产市场分为上游设备、下游设备、生物反应器、耗材及配件。到 2022 年，消耗品和配件领域将占据欧洲最大的生物生产市场。

就最终用户而言，欧洲生物生产市场分为生物製药公司、合约製造组织等。到 2022 年，生物製药公司领域将占据欧洲最大的生物生产市场。

依国家/地区划分，欧洲生物生产市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲生物生产市场份额中占据主导地位。

Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是营运中的一些领先公司在欧洲生物生产市场。

Cardiovascular diseases (CVDs), neurological disorders, autoimmune disorders, and cancer are among the chronic diseases causing death and disabilities at a significant rate worldwide. As per the World Health Organization (WHO), CVDs are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Cancer is also among the leading causes of mortality worldwide, affecting a huge population; therefore, it acts as a huge financial burden on society. According to the WHO, in 2020, ~10 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is positively affecting the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis' Kymriah is used to treat diffuse large B-cell lymphoma.

Moreover, recognition of biosimilars as efficacious and safe agents by patients, specialists, primary care clinicians, and other healthcare professionals is propelling the demand for biosimilars. In addition, biosimilars help improve life of millions of patients while saving billions of dollars of the healthcare system per year. They are effective and cost-effective options in treating many diseases, including chronic skin conditions and bowel diseases such as Crohn's disease, psoriasis, irritable bowel syndrome, and colitis; diabetes; autoimmune disease; cancer; kidney conditions; and arthritis.

As the prevalence of chronic diseases is increasing at a high rate, the demand for bioproduction in treating life-threatening illnesses has progressed rapidly over the last five years, thereby driving the bioproduction market.

Europe Bioproduction Market Overview

The Europe bioproduction market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global bioproduction market and is estimated to register a notable CAGR during 2022-2030. The increasing prevalence of chronic disorders has resulted in a growing number of product launches and approvals, along with technological advancements and investment, thereby contributing to the market growth in the region.

Biosimilars introduce competition and increase the affordability of biologics, which ultimately deliver savings and value-added services to support patient care and the healthcare industry. Healthcare professionals can treat more patients with high-quality biologics at reduced cost. Due to the massive potential for cost savings, the German Health Ministry introduced a new law to increase the adoption of biosimilars. As a few European Union (EU) countries allow pharmacist substitution of biosimilars, this would represent a significant change in practice, particularly for Germany. In addition, healthcare providers such as PHI Orthopedic Physiotherapy Center, German International Clinic, Frankfurt, Germany; CBC Health Munich, Germany; and other providers offer stem cell therapy for various chronic diseases such as diabetic retinopathy, optic nerve neuritis, and rheumatoid arthritis. This is expected to increase the adoption of cell therapies in the coming years. Also, a growing number of partnerships among international players boost the market growth. For instance, in November 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC and apceth Biopharma GmbH expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies, including expanded commercial drug product manufacturing capacity in Europe for ZYNTEGLO, a one-time gene therapy for transfusion-dependent B-thalassemia (TDT). Therefore, with the growing government initiatives for adopting biosimilars in Germany, the market is expected to flourish.

Europe Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

Europe Bioproduction Market Segmentation

The Europe bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the Europe bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest Europe bioproduction market share in 2022.

In terms of application, the Europe bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest Europe bioproduction market share in 2022.

By equipment, the Europe bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest Europe bioproduction market share in 2022.

In terms of end user, the Europe bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest Europe bioproduction market share in 2022.

By country, the Europe bioproduction market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe bioproduction market share in 2022.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the Europe bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - Europe Market Analysis

5.1 Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe: Bioproduction Market
- 10.1.1 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
  - 10.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.2 Germany: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.1.3 Germany: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4 Germany: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.4.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.5 Germany: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 UK: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 UK: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 UK: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 UK: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 France: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 France: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 France: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Italy: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Italy: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Italy: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.5.4 Spain: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.5.5 Spain: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.6 Spain: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.6 Rest of Europe: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 . Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 bbi-biotech GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Bioproduction Market Segmentation
Table 2. Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. France Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. Europe Bioproduction Market Segmentation, By Country
Figure 2. Europe Bioproduction Market: Key Industry Dynamics
Figure 3. Europe Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market